BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36426920)

  • 1. Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma.
    Huang X; Zhou H; Yang X; Shi W; Hu L; Wang J; Zhang F; Shao F; Zhang M; Jiang F; Wang Y
    J Clin Lab Anal; 2022 Dec; 36(12):e24777. PubMed ID: 36426920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA ZBED5-AS1 Facilitates Tumor Progression and Metastasis in Lung Adenocarcinoma via ZNF146/ATR/Chk1 Axis.
    Jiang F; Huang X; Ling L; Tang S; Zhou H; Cai X; Wang Y
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma.
    Jin D; Song Y; Chen Y; Zhang P
    Biomed Res Int; 2020; 2020():7573689. PubMed ID: 32149133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.
    Kang H; Ma D; Zhang J; Zhao J; Yang M
    BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
    Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
    J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
    Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y
    J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis.
    Zhang X; Bao L; Yu G; Wang H
    Front Surg; 2022; 9():1050242. PubMed ID: 36684253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
    Pan C; Wang Q; Wang H; Deng X; Chen L; Li Z
    Carcinogenesis; 2024 May; 45(5):311-323. PubMed ID: 38153696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
    Li L; Peng M; Xue W; Fan Z; Wang T; Lian J; Zhai Y; Lian W; Qin D; Zhao J
    J Transl Med; 2018 Dec; 16(1):372. PubMed ID: 30587197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.
    Liu J; Pan C; Lu R; Zhang S
    Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
    Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X
    J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells.
    Tian X; Zhang H; Zhang B; Zhao J; Li T; Zhao Y
    Oncol Rep; 2017 Jul; 38(1):293-300. PubMed ID: 28586074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.
    Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR
    Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
    Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
    Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
    Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
    Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.